These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 11796341)
1. Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance. Goñi-Urriza M; Arpin C; Capdepuy M; Dubois V; Caumette P; Quentin C Antimicrob Agents Chemother; 2002 Feb; 46(2):350-9. PubMed ID: 11796341 [TBL] [Abstract][Full Text] [Related]
2. An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients. Sinha S; Chattopadhyay S; Bhattacharya SK; Nair GB; Ramamurthy T Res Microbiol; 2004 Dec; 155(10):827-9. PubMed ID: 15567276 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of quinolone resistance in Aeromonas species isolated from humans, water and eels. Alcaide E; Blasco MD; Esteve C Res Microbiol; 2010; 161(1):40-5. PubMed ID: 19900538 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of quinolone resistance in clinical isolates of Aeromonas caviae and Aeromonas veronii bv. sobria. Arias A; Seral C; Gude MJ; Castillo FJ Int Microbiol; 2010 Sep; 13(3):135-41. PubMed ID: 20890847 [TBL] [Abstract][Full Text] [Related]
5. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae. Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and characterisation of quinolone resistance genes in Aeromonas spp. isolated from pet turtles in South Korea. Wimalasena SHMP; De Silva BCJ; Hossain S; Pathirana HNKS; Heo GJ J Glob Antimicrob Resist; 2017 Dec; 11():34-38. PubMed ID: 28743647 [TBL] [Abstract][Full Text] [Related]
7. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Jorgensen JH; Weigel LM; Ferraro MJ; Swenson JM; Tenover FC Antimicrob Agents Chemother; 1999 Feb; 43(2):329-34. PubMed ID: 9925527 [TBL] [Abstract][Full Text] [Related]
8. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Valdezate S; Vindel A; Echeita A; Baquero F; Cantó R Antimicrob Agents Chemother; 2002 Mar; 46(3):665-71. PubMed ID: 11850246 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of fluoroquinolone-resistant Aeromonas spp. isolated from imported shrimp. Shakir Z; Khan S; Sung K; Khare S; Khan A; Steele R; Nawaz M Appl Environ Microbiol; 2012 Nov; 78(22):8137-41. PubMed ID: 22923408 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of type II topoisomerases of Aeromonas hydrophila isolated from fish and levofloxacin-induced resistant isolates in vitro. Hu R; Du N; Chen N; Lin L; Zhai Y; Gu Z Folia Microbiol (Praha); 2016 May; 61(3):249-53. PubMed ID: 26503714 [TBL] [Abstract][Full Text] [Related]
11. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Akasaka T; Tanaka M; Yamaguchi A; Sato K Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683 [TBL] [Abstract][Full Text] [Related]
12. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Mouneimné H; Robert J; Jarlier V; Cambau E Antimicrob Agents Chemother; 1999 Jan; 43(1):62-6. PubMed ID: 9869566 [TBL] [Abstract][Full Text] [Related]
13. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae. Lindbäck E; Rahman M; Jalal S; Wretlind B APMIS; 2002 Sep; 110(9):651-7. PubMed ID: 12529019 [TBL] [Abstract][Full Text] [Related]
14. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda. Kim MS; Jun LJ; Shin SB; Park MA; Jung SH; Kim K; Moon KH; Jeong HD J Microbiol Biotechnol; 2010 Dec; 20(12):1735-43. PubMed ID: 21193831 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and characterization of plasmid-mediated quinolone resistance genes in Aeromonas spp. isolated from South African freshwater fish. Chenia HY Int J Food Microbiol; 2016 Aug; 231():26-32. PubMed ID: 27180024 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii. Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea. Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947 [TBL] [Abstract][Full Text] [Related]
18. Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro. Dessus-Babus S; Bébéar CM; Charron A; Bébéar C; de Barbeyrac B Antimicrob Agents Chemother; 1998 Oct; 42(10):2474-81. PubMed ID: 9756744 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of quinolone resistance and clonal relationship among Aeromonas salmonicida strains isolated from reared fish with furunculosis. Giraud E; Blanc G; Bouju-Albert A; Weill FX; Donnay-Moreno C J Med Microbiol; 2004 Sep; 53(Pt 9):895-901. PubMed ID: 15314197 [TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci. González I; Georgiou M; Alcaide F; Balas D; Liñares J; de la Campa AG Antimicrob Agents Chemother; 1998 Nov; 42(11):2792-8. PubMed ID: 9797205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]